Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.

Saved in:
Bibliographic Details
Title: Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.
Authors: Magaton IM; Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; University Women`s Hospital, Inselspital, Bern, Switzerland., Blondeaux E; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Hamy AS; Department of Medical Oncology, Université Paris Cité, Institut Curie, Paris, France., Linn S; Department of Molecular Pathology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands and Deptment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Bernstein-Molho R; Susanne Levy Gertner Oncogenetics Unit, Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Centre affiliated to Tel Aviv University, Tel Hashomer, Israel., Peccatori FA; Gynaecology Oncology Program, European Institute of Oncology (IRCCS), Milan, Italy., Ferrari A; Hereditary Breast and Ovarian Cancer (HBOC) Unit and General Surgery 3 - Senology, Surgical Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy & University of Pavia, Italy., Carrasco E; Hereditary Cancer Genetics Unit, Medical oncology Department, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain., Paluch-Shimon S; Faculty of Medicine, Hebrew University, Jerusalem, Israel; Breast Oncology Unit, Sharett Institute of Oncology, Hadassah University Hospital, Hebrew University, Jerusalem, Israel., Agostinetto E; Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Venturelli M; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Luis IMV; Cancer survivorship program - Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Rodriguez-Wallberg KA; Department of Oncology/Pathology, Karolinska Institute and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea., Sorouri K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Gynaecology Obstetrics & Gynaecology, University of Alberta, Edmonton, AB, Canada., Renaud T; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France., Moore HCF; Department of Haematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland OH, USA., Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Bajpa J; Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Centre; Hôpital Femme Mère Enfant; and INSERM U 1290 RESHAPE, Lyon, France., De Marchis L; Division of Medical Oncology, Department of Radiological, Oncological and Pathological Sciences, 'La Sapienza' University of Rome, Rome, Italy; Medical Oncology Department of Hematology, Oncology and Dermatology, Umberto I University Hospital, Rome, Italy., Yerushalmi R; Davidoff Centre, Rabin Medical Centre, Petah Tikva, Tel-Aviv University, Tel-Aviv, Israel., Wong SM; Stroll Cancer Prevention Centre, Jewish General Hospital, and McGill University Medical School, Montreal, Canada., Han S; Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Roentgena 5, Warsaw, Poland., Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy; Department of Medicine, University of Udine, Udine, Italy., Chirco A; SC Oncologia- ASST Papa Giovanni XXIII, Bergamo, Italy., Duhoux FP; Department of Medical Oncology, King Albert II Cancer Institute, Cliniques universitaires Saint-Luc and Institut de Recherche Expérimentale et Clinique (Pôle MIRO), UCLouvain, Brussels, Belgium., Meattini I; Department of Experimental and Clinical Biomedical Sciences 'M. Serio', University of Florence, Florence, Italy & Breast Unit and Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Villarreal-Garza C; Tecnologico de Monterrey, Breast Cancer Center, Hospital Zambrano Hellion, TecSalud, Monterrey, Mexico., Vernieri C; Medical Oncology Department, Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Oncology and Haematology-Oncology Department, University of Milan, Milan, Italy., Bruzzone M; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Demeestere I; Department of Obstetrics and Gynaecology, Fertility Clinic HUB Erasme (U.L.B), Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles (U.L.B), Brussels, Belgium., Azim HA Jr; Cairo Cure Oncology Centre, Cairo, Egypt., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lambertini M; Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genoa, Italy. Electronic address: matteo.lambertini@unige.it.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jun 03; Vol. 222, pp. 115434. Date of Electronic Publication: 2025 Apr 14.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first